|1.||Takasu, Nobuyuki: 2 articles (01/2012 - 03/2008)|
|2.||Amino, Nobuyuki: 2 articles (07/2006 - 12/2003)|
|3.||Wallaschofski, H: 2 articles (07/2002 - 10/2000)|
|4.||Miehle, K: 2 articles (07/2002 - 10/2000)|
|5.||Hentschel, B: 2 articles (07/2002 - 10/2000)|
|6.||Paschke, R: 2 articles (07/2002 - 10/2000)|
|7.||Takasu, N: 2 articles (04/2001 - 08/2000)|
|8.||Nagata, A: 2 articles (04/2001 - 08/2000)|
|9.||Sato, Y: 2 articles (04/2001 - 08/2000)|
|10.||Yamashiro, K: 2 articles (04/2001 - 08/2000)|
01/01/2012 - "All of the 10 TSBAb-positive goitrous patients recovered from hypothyroidism and 19 (79%) of the 24 TSBAb-positive atrophic patients continued to have hypothyroidism."
01/01/1998 - "In the present study, we attempted to determine whether hypothyroidism that develops within a shorter period of time following 131I therapy is associated with TSBAb. "
08/01/1988 - "The prevalence of TSBAb in patients with primary atrophic hypothyroidism varies in different studies, from 0 to 47%. "
01/01/2012 - "We followed 34 TSBAb-positive patients with hypothyroidism (24 atrophic and 10 goitrous) over 10 years. "
01/01/2012 - "With the disappearance of TSBAb, recovery from hypothyroidism was noted in 13 (87%) of the 15 patients. "
|2.||Graves Disease (Basedow Disease)
02/01/2006 - "At the first survey, the prevalences of positive TSAb, TBII and TSBAb were found in 80.9%, 61.7% and 6.4% of the patients with Graves' disease respectively. "
12/01/2003 - "We found that activities of TSH-binding inhibitory Igs, TSAb, and TSBAb decrease during pregnancy and increase after delivery, suggesting that amelioration of Graves' disease during pregnancy is induced by decrease of TSAb but not by the appearance of TSBAb."
11/01/2003 - "Use of human recombinant monoclonal TSBAb may be an analytical tool for molecular-basis etiology and an alternative therapeutic path for Graves' disease."
09/01/2001 - "We measured stimulating TSHRAb (TSAb) activities using CHO-hTSHR cells, FRTL-5 cells and chimeric receptor expressing cells (Mc1 + 2 and Mc2), specific blocking TSHRAb (TSBAb) activities using Mc2 cells and TBII activities using porcine thyroid membrane in 136 patients with untreated hyperthyroid Graves' disease. "
03/01/1999 - "Whether this increased sensitivity for the determination of TSBAB is of prognostic significance for detecting possible sequential changes in the individual TSHR AB profile of patients with Graves' disease, remains to be determined by further follow up studies."
01/01/2011 - "We report a rare case of a young boy with atrophic thyroiditis caused by TSBab."
04/10/2003 - "[Destructive thyroiditis with elevated thyroid stimulation blocking antibody]."
07/01/1989 - "In a patient with goitrous chronic thyroiditis, TBII, TSAb and TSBAb were not detected at the initial hypothyroid phase. "
01/01/1994 - "Studies of human thyroid xenografts from Hashimoto's thyroiditis in severe combined immunodeficient (SCID) mice: detection of thyroid stimulation-blocking antibody."
09/01/2003 - "Although a thyroid stimulation-blocking antibody was also detected in this patient, we thought that hypothyroidism in this case was based on destructive change in the thyroid with Hashimoto's thyroiditis. "
12/01/1990 - "Seven patients had hyperthyroidism, when they had TSAb, which stimulated the thyroid gland; one of these seven patients had TSBAb during the hypothyroid state and TSAb during the hyperthyroid state, indicating that the alterations in the thyroid state related to the balance between the activities of TSAB and TSBAb. "
07/01/1990 - "Six of the 7 subjects who developed hyperthyroidism had elevated TSAb and negative TSBAb titers while they were euthyroid. "
04/01/1988 - "When hyperthyroidism subsequently occurred, TSBAb became negative (30.9%), while TSBAb became positive (163.3%). "
01/01/2012 - "TSBAb-hypothyroidism and TSAb-hyperthyroidism may be two aspects of one disease (TRAb disease). "
01/01/2012 - "Two of the 98 TSAb-positive Graves' patients with hyperthyroidism developed TSBAb-positive hypothyroidism. "
08/01/1999 - "Form these findings, it is suggested that TSBab may play a certain pathogenetic role in idiopathic myxedema."
08/01/1999 - "TSBab is disappeared in some cases of TSBab positive idiopathic myxedema during treatment. "
08/01/1999 - "TSBab is positive in 20-30% cases of idiopathic myxedema. "
07/01/1989 - "In a patient with primary nongoitrous myxedema, initially high TBII and TSBAb were detected without TSAb activity. "
07/01/1989 - "TBII activities of patients with primary myxedema were significantly correlated with both their TSBAb (r = 0.665; p less than 0.01) and TGBAb (r = 0.618; p less than 0.01) activities. "
|1.||Thyrotropin Receptors (Thyrotropin Receptor)
|3.||thyroid stimulation-blocking antibody
|7.||Thyrotropin (Thyroid-Stimulating Hormone)
|10.||thyrotropin-binding inhibitory immunoglobulin
|1.||Heterologous Transplantation (Xenotransplantation)